Cargando…
A New Mouse Model for the Study of Human Breast Cancer Metastasis
Breast cancer is the most common cancer in women, and this prevalence has a major impact on health worldwide. Localized breast cancer has an excellent prognosis, with a 5-year relative survival rate of 85%. However, the survival rate drops to only 23% for women with distant metastases. To date, the...
Autores principales: | Iorns, Elizabeth, Drews-Elger, Katherine, Ward, Toby M., Dean, Sonja, Clarke, Jennifer, Berry, Deborah, Ashry, Dorraya El, Lippman, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485320/ https://www.ncbi.nlm.nih.gov/pubmed/23118918 http://dx.doi.org/10.1371/journal.pone.0047995 |
Ejemplares similares
-
Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer
por: Miller, Philip C., et al.
Publicado: (2019) -
Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer
por: Dey, Parama, et al.
Publicado: (2020) -
Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses
por: Azzam, Diana J, et al.
Publicado: (2013) -
RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer
por: Magna, Melinda, et al.
Publicado: (2023) -
Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression
por: McCarthy, James B., et al.
Publicado: (2018)